SEARCH FOR SCI CURE: Injectable Peptide might help Spinal Cord Injury patients walk again

Researcher Jerry Silver

A systemically injectable peptide, which may make it possible to restore lost functions in spinal cord injury patients, is moving toward clinical trials in early 2020. The treatment, which was developed by Jerry Silver, a professor of neurosciences at Case Western Reserve University’s School of Medicine and advisor for NervGen Pharma, is the culmination of decades of work, and in pre-clinical studies, it has shown robust results in animal models.

Pre-clinical studies in rats have shown significant recoveries, with every animal showing improved bladder function and more than a third of animals regaining their ability to walk. This work has been independently replicated with an increased dosage, which showed even better recovery.

Now, before you get all excited, while this concept is unique, please notice that they are at early stages with this approach. Many claims/hopes are made with such studies, so read more about his work HERE.